These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo. Klueh U; Antar O; Qiao Y; Kreutzer DL J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180 [TBL] [Abstract][Full Text] [Related]
43. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Brito BE; O'Rourke LM; Pan Y; Anglin J; Planck SR; Rosenbaum JT Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2583-9. PubMed ID: 10509653 [TBL] [Abstract][Full Text] [Related]
44. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259 [TBL] [Abstract][Full Text] [Related]
45. Biologic basis for interleukin-1 in disease. Dinarello CA Blood; 1996 Mar; 87(6):2095-147. PubMed ID: 8630372 [TBL] [Abstract][Full Text] [Related]
46. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Korherr C; Hofmeister R; Wesche H; Falk W Eur J Immunol; 1997 Jan; 27(1):262-7. PubMed ID: 9022028 [TBL] [Abstract][Full Text] [Related]
47. Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. van Enckevort FH; Sweep CG; Span PN; Demacker PN; Hermsen CC; Hermus AR J Endocrinol Invest; 2001 Nov; 24(10):786-95. PubMed ID: 11765048 [TBL] [Abstract][Full Text] [Related]